Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it initiated a share repurchase program for up to 5 million shares to cover certain of its obligations arising from its long-term incentive and employee stock purchase plans. At the current share price, this program represents an amount of up to EUR 174 million. The program commences today and is expected to be completed before November 10, 2018. Philips will provide updates on the progress of the program. Further details are available via this link. Philips will hold the repurchased shares in treasury until the shares are to be delivered. The program will be executed by an intermediary to allow for purchases in the open market during both open and closed periods, in accordance with the Market Abuse Regulation and within the limits of the authorization granted by the company’s General Meeting of Shareholders on May 3, 2018.
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.
Philips Global Press Office Tel: +31 6 1521 3446
You are about to visit a Philips global content page
Continue Philips Investor Relations Tel: +31 20 59 77055
You are about to visit a Philips global content page
ContinueGet our press releases by e-mail
You are about to visit a Philips global content page
Continue